The Evolution and Future of TAVR

The Evolution and Future of TAVR

In this presentation, cardiac surgeon Prashanth Vallabhajosyula, MD, reviews the Penn Medicine TAVR program-among the first and now among the largest in the nation-and describes the evolution, indications, outcomes and current options for TAVR therapy. Dr. Vallabhajosyula also provides surgical perspective for the procedure, describing the evolution of the minimalist approach at Penn, fast­-track criteria, precluding risk factors for TAVR and comparisons between TAVR and open AVR/MVR.

 

Related Links


Published

May 12, 2016

Created by

Penn Physician VideoLink